Compass Therapeutics, Inc. Stock
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
18:10:55 17/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.295 USD | +2.00% |
|
+3.15% | -57.36% |
| Market Cap | 405M 350M 329M 299M 562M 38.75B 572M 3.85B 1.51B 19.4B 1.52B 1.49B 64.48B | P/E 2026 * |
-4.57x | P/E 2027 * | -4.24x |
|---|---|---|---|---|---|
| Enterprise Value | 255M 220M 207M 188M 354M 24.4B 360M 2.43B 949M 12.22B 958M 937M 40.61B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.7x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | +2.00% | ||
| 1 week | +3.15% | ||
| Current month | +19.90% | ||
| 1 month | +11.71% | ||
| 3 months | +25.14% | ||
| 6 months | -64.16% | ||
| Current year | -57.36% |
| 1 week | 2.16 |  | 2.38 |
| 1 month | 1.85 | | 2.38 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/02/26 | Tax | Chief Executive Officer | 36,687 | 0.0206% | ||
| 09/01/26 | Tax | Chief Executive Officer | 46,777 | 0.0263% | ||
| 02/01/26 | Free | Director | 90,000 | 0.0506% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.00% | +3.15% | -20.21% | -3.78% | 405M | |
| -1.90% | +2.85% | +62.82% | +104.39% | 70.07B | |
| +15.86% | +10.27% | +47.51% | +85.24% | 52.87B | |
| +2.79% | -6.25% | -0.74% | +475.01% | 27.02B | |
| +2.26% | +0.09% | +48.90% | +11.90% | 23.61B | |
| -0.84% | -0.41% | -17.89% | -18.37% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +477.93% | 19.43B | |
| +3.65% | +6.33% | +40.50% | -14.70% | 18.75B | |
| +0.38% | -1.14% | +16.94% | +567.31% | 15.85B | |
| +0.76% | -3.44% | +35.43% | +143.52% | 12.7B | |
| Average | +2.88% | -0.33% | +47.96% | +182.85% | 26.41B | |
| Weighted average by Cap. | +3.68% | -1.40% | +54.05% | +167.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 23.35M 20.17M 18.95M 17.24M 32.41M 2.23B 32.94M 222M 86.83M 1.12B 87.67M 85.77M 3.72B |
| Net income | -93.55M -80.8M -75.93M -69.05M -130M -8.95B -132M -890M -348M -4.48B -351M -344M -14.89B | -105M -91.03M -85.54M -77.8M -146M -10.08B -149M -1B -392M -5.05B -396M -387M -16.77B |
| Net Debt | -150M -130M -122M -111M -208M -14.34B -212M -1.43B -558M -7.18B -563M -551M -23.87B | -133M -115M -108M -98.17M -185M -12.72B -188M -1.26B -495M -6.37B -499M -489M -21.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | $2.285 | +1.56% | 195,566 |
| 14/08/26 | $2.250 | -0.44% | 1,362,180 |
| 13/08/26 | $2.260 | -4.64% | 2,272,293 |
| 12/08/26 | $2.370 | +7.73% | 8,291,258 |
| 11/08/26 | $2.200 | -0.90% | 3,984,649 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
